All releases
04/16/2013
Sales growth of 3.6% in the first quarter
03/11/2013
A 15.8% net profit increase in 2012
01/17/2013
Sales growth of 11.5% in 2012
11/23/2012
Virbac becomes a leader of the aquaculture health market
10/18/2012
Steady growth of sales in the third quarter
08/31/2012
Strong growth of half-year earnings
07/19/2012
Continued solid sales growth in the second quarter
06/25/2012
Virbac acquires Stockguard in New Zealand
06/20/2012
Shareholders information about the modification of the dates in which the dividend to be distributed will be detached from the share and will be payable
04/18/2012
Solid sales growth in the first quarter
03/12/2012
2011 results: sound growth of current earnings
01/19/2012
Sales grow 8.7% in 2011
11/14/2011
VIRBAC ENTERS IN A NEW TECHNOLOGY ALLIANCE IN FOOD-PRODUCING ANIMALS VACCINES
10/18/2011
Continuation of the growth trend in the third quarter
08/31/2011
HALF YEAR RESULTS : Strong increase of the current operating profit
07/18/2011
FIRST HALF-YEAR SALES : A 10.7% GROWTH
04/19/2011
Strong sales growth in the first quarter
03/17/2011
Canine leishmaniosis: the CaniLeish® vaccine* obtains a European registration
03/14/2011
2010 RESULTS: Historic growth of sales and net earnings
01/19/2011
2010 sales: a 22.5% growth
01/13/2011
Canine leishmaniasis: a decisive step towards registration of the CaniLeish* vaccine
10/13/2010
Sales growth still strong in the third quarter
09/01/2010
Strong increase of first half results
07/16/2010
A strong growth in the first half
04/14/2010
High sales growth in the first quarter
03/15/2010
Increase of 2009 earnings beside the global economic crisis
03/05/2010
Virbac enters into an alliance in food-producing animal vaccines
02/02/2010
Virbac announces close of acquisition of veterinary assets from Pfizer in Australia
01/19/2010
Annual sales grow by 5.4% in 2009
01/12/2010
Virbac to acquire veterinary assets from Pfizer in Australia
1   - 2
Sales growth of 3.6% in the first quarter
A 15.8% net profit increase in 2012
Sales growth of 11.5% in 2012
Virbac becomes a leader of the aquaculture health market
Steady growth of sales in the third quarter
Press releases
Shareholders and stock market
Facts & figures
Communication timetable
Regulated information
Ok
PUBLICATION
CONTACT

 VIRBAC WORLDWIDE